Cargando…
Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD
RATIONALE & OBJECTIVE: The accuracy of glycated hemoglobin (HbA(1c)) level for assessment of glycemic control in patients with chronic kidney disease (CKD) is uncertain. This study assessed the accuracy of HbA(1c) level using continuous glucose monitoring. STUDY DESIGN: Diagnostic test study of...
Autores principales: | Presswala, Lubaina, Hong, Susana, Harris, Yael, Romao, Isabela, Zhang, Meng, Jhaveri, Kenar D., Sakhiya, Vipul, Fishbane, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380426/ https://www.ncbi.nlm.nih.gov/pubmed/32734208 http://dx.doi.org/10.1016/j.xkme.2019.07.006 |
Ejemplares similares
-
SAT-128 Evaluating the Accuracy of Glycemic Markers and Risk of Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease by Continuous Glucose Monitoring
por: Presswala, Lubaina, et al.
Publicado: (2019) -
The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced CKD
por: Sakhiya, Vipul, et al.
Publicado: (2019) -
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review
por: Jhaveri, Kenar D., et al.
Publicado: (2016) -
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
por: Ng, Jia H., et al.
Publicado: (2020) -
Home Dialysis in the Time of COVID-19: Reflections on Rapidly Changing Policies
por: Sachdeva, Mala, et al.
Publicado: (2020)